Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126670551 | 12667055 | 1 | I | 20160422 | 0 | 20160818 | 20160818 | DIR | 48.00 | YR | F | N | 180.00000 | LBS | 20160817 | N | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126670551 | 12667055 | 1 | PS | TAMOXIFEN CITRATE. | TAMOXIFEN CITRATE | 1 | Oral | 30 TABLET(S) ONCE A DAY TAKEN BY MOUTH | N | N | 1067482M | 20180930 | 0 | 30 | DF | COATED TABLET | QD | ||
| 126670551 | 12667055 | 3 | C | DIAMOXX | 2 | 0 | |||||||||||||
| 126670551 | 12667055 | 5 | C | OXYCODONE | OXYCODONE | 1 | 0 | ||||||||||||
| 126670551 | 12667055 | 7 | C | XANAX | ALPRAZOLAM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126670551 | 12667055 | 1 | Breast cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126670551 | 12667055 | DS |
| 126670551 | 12667055 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126670551 | 12667055 | Benign intracranial hypertension |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126670551 | 12667055 | 1 | 20160811 | 0 |